The mechanism of transformation of biliary epithelium leading to intestinal metaplasia, which is significantly involved in biliary diseases, remains unclear. CDX2, an intestine-specific transcription factor, is thought to regulate intestinal mucin MUC2 (mucus core protein) expression. We took advantage of polycystic kidney (PCK) rats as a model of chronic suppurative cholangitis with intestinal metaplasia and of cultured biliary epithelial cells (BECs) from PCK rats to clarify the causal relation between bacterial components such as pathogen-associated molecular patterns (PAMPs) and the development of intestinal metaplasia of bile ducts. Histological, immunohistochemical, and in situ hybridization studies were conducted in PCK rat livers. In cultured BECs, CDX2 and MUC2 were expressed following treatment with PAMPs and inhibitors (anti-Toll-like receptor (TLR)2/TLR4 antibody, nuclear factor-kB (NF-kB) inhibitor MG132). Chronic suppurative cholangitis with intestinal metaplasia developed as the PCK rats aged, and intestinal metaplasia and aberrant CDX2 and MUC2 expression developed in parallel. Intraluminal bacteria and the expression of TLR2 and TLR4 in BECs were demonstrated in the bile ducts, showing chronic suppurative cholangitis. In cultured BECs, treatment with PAMPs induced upregulation of CDX2 and MUC2 expression, and this effect was abolished by pretreatment with anti-TLR2 and anti-TLR4 antibody and MG132. A knockdown of CDX2 by CDX2 small interfering RNA inhibited MUC2 expression in cultured BECs induced by PAMPs, and transfection of CDX2 expression vector induced MUC2 expression. In conclusion, bacterial components may induce upregulation of the CDX2 expression followed by MUC2 expression via TLR and the NF-kB system in cultured BECs, and could be related to the development of intestinal metaplasia of the bile ducts. 1-4 is reportedly involved in tumorigenesis in several organs. Recent studies revealed that CDX2, a caudalrelated homeobox gene encoding an intestine-specific transcription factor, is a regulatory factor of intestinal development and expression of intestinal genes including MUC2 and is involved in intestinal metaplasia.
Mucus core protein (MUC) forms the backbone protein of mucin. Sixteen types of MUC have been identified. Intestinal metaplasia associated with the aberrant expression of MUC2 [1] [2] [3] [4] is reportedly involved in tumorigenesis in several organs. Recent studies revealed that CDX2, a caudalrelated homeobox gene encoding an intestine-specific transcription factor, is a regulatory factor of intestinal development and expression of intestinal genes including MUC2 and is involved in intestinal metaplasia.
2,4,5-8 CDX2-dependent intestinal metaplasia is noted in Barrett's esophagus with MUC2 expression, and bile acid and chronic acid exposure have been reported to induce CDX2 expression. 2, [4] [5] [6] 8, 9 Intestinal metaplasia is also involved in the pathogenesis of biliary diseases. For example, in chronic cholangitis such as hepatolithiasis, intestinal metaplasia with goblet cells occurs, and MUC2 is aberrantly expressed in goblet cells colocalized with CDX2. 1, [10] [11] [12] [13] [14] [15] [16] [17] [18] Bacterial infections are implicated in chronic cholangitis with intestinal metaplasia. 19, 20 Lipopolysaccharide (LPS), a bacterial component, is known to cause MUC2 overexpression in cultured biliary epithelial cells (BECs). 21 Reportedly, Toll-like receptors (TLRs) play an important role as receptors recognizing pathogen-associated molecular patterns (PAMPs) such as LPS, lipoteichoic acid (LTA), and peptidoglycan (PGN). Among them, TLR2 mediates signal transduction for LTA, PGN, and synthetic lipopeptide Pam3Cys-sKKKK Â 3HCl (Pam3), and TLR4 is a receptor for LPS. [22] [23] [24] So far, the molecular mechanism of intestinal metaplasia and aberrant expression of CDX2 and MUC2 in bile ducts, particularly their relation to bacterial components, remain unexplored.
In this study, the participation of MUC2, CDX2, TLR, and bacterial products in biliary intestinal metaplasia was examined, by using polycystic kidney (PCK) rats which are an animal model of Caroli's disease showing multiple dilatation of intrahepatic bile ducts with chronic cholangitis and also cultured BECs from PCK rats. 25 
MATERIALS AND METHODS PCK and Crj:CD Rats
All rats were obtained from Charles River Japan (Sagamihara, Japan), and handled according to the Guidelines for the Care and Use of Laboratory Animals of the Kanazawa University. Crj:CD rats were used as controls. These rats were killed in sequence from 18 days of gestation to 16 months (Table 1) .
Tissues
Sections from each liver were fixed in 10% formalin. More than 20 thin sections were cut from each paraffin block, and some were processed for histologic study by hematoxylineosin (H&E), periodic acid Schiff (PAS), and Gram's staining. The intrahepatic bile ducts were examined. The rest were used for immunohistochemistry. Parts of fresh liver from PCK and control rats were used for Western blotting. The biliary trees were isolated from the liver of PCK rats by perfusion with collagenase solution as described previously. 21 Bile Bile samples that were obtained from the common bile duct lumen of PCK rats by cannulation were used for the identification of bacterial species.
Culture of BECs
Intrahepatic BECs were isolated from 8-week-old male PCK and control rats, and cultured. 21 Subcultured BECs from the 6th to 9th passage were used. There were no goblet cells or MUC2-positive cells among the isolated BECs.
Antibodies and Other Reagents
Antibodies and reagents are shown in Table 2 . Among them, anti-CDX2 antibody against human tissue is reported to react with rat CDX2, 8, 9 and our preliminary study also confirmed that this antibody reacted with the nuclei of cell of the small intestinal epithelium of PCK rats. Therefore, we used this antibody in this study using rat specimens.
Immunohistochemistry MUC2, CDX2, TLR2, and TLR4 expression were examined immunohistochemically in the bile ducts from livers from 60 PCK rats (6 weeks to 10 months) and in cultured BECs on collagen gel. The latter were fixed in paraformaldehyde, and more than 20 thin sections were cut from each paraffin block. Briefly, deparaffinized sections were microwaved in citrate buffer for MUC2 and CDX2, and were treated with proteinase K for TLR2 and TLR4. These sections were then incubated with each primary antibody, and incubated with goat anti-mouse or rabbit immunoglobulins conjugated to peroxidase-labeled polymer (Envision þ ). Diaminobenzidine tetrahydrochloride was used as a chromogen. Double fluorescent immunostaining for MUC2 and CDX2 was performed using three PCK rats expressing MUC2 and CDX2 in the bile ducts and cultured BECs. Deparaffinized sections were microwaved in citrate buffer, and then incubated with rabbit polyclonal antibody to MUC2 and mouse monoclonal antibody to CDX2. After incubation with Alexa Fluor 488 goat anti-rabbit immunoglobulin G (IgG) and Alexa Fluor 594 goat anti-mouse IgG, nuclei were stained by 4 0 ,6-diamino-2-phenylindole, dihydrochloride (DAPI), and examined under a confocal laser microscope LSM5 (Carl Zeiss, Oberkochen, Germany). Control rats Fetus means rats from 18 to 21 days of gestation; suppurative cholangitis was regarded as cholangitis with infiltration of PMNs in biliary lumen. a Po0.01 compared with control rats at each age. Po0.01 compared with 6-10 weeks in PCK rats. c Po0.05 compared with control rats at each age.
d Po0.01 compared with 4-7 months in PCK rats.
e Po0.05 compared with 4-7 months in PCK rats.
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Small intestinal samples of PCK rats served as positive controls for CDX2 immunostaining. Negative controls were evaluated using normal mouse or rabbit serum.
In Situ Hybridization for MUC2 and CDX2 mRNA Digoxigenin-labeled RNA probes for MUC2 and CDX2 were made by in vitro transcription using reverse transcriptionpolymerase chain reaction (RT-PCR) products as a template (Boehringer Mannheim, Mannheim, Germany) and SP6/T7 RNA polymerases.
14 PCR primers used were as follows:
0 . Briefly, deparaffinized sections of PCK and control rats were treated with proteinase K, and then dehydration and hybridization were performed.
Western Blotting
Protein was extracted from fresh whole livers, freshly isolated biliary trees, and cultured BECs isolated from 8-week-old PCK rats, using Tissue Protein Extraction Reagent, 21 and total protein was measured spectrometrically. Anti-CDX2 antibody, anti-MUC2 antibody, and anti-b-actin antibody were used as the primary antibody. CDX2 protein was specifically concentrated by the immunoprecipitation using primary antibody to CDX2 and protein G-agarose beads (Roche, Indianapolis, IN, USA). Immunoblots were visualized with an enhanced chemiluminescence system.
RT-PCR
Total RNA was extracted from cultured BECs by using the RNeasy Total RNA System. After complementary DNA was synthesized, a semiquantitative RT-PCR was carried out. The sequence of the primers and conditions for PCR are shown in Table 3 . The density of band(s) was semiquantitatively analyzed, using NIH image. To assess the involvement of TLR, BECs were preincubated with polyclonal rabbit anti-rat TLR2/TLR4 antibody or control IgG as a negative control, and then incubated with Pam3/LPS. To examine the involvement of the nuclear factorkB (NF-kB) signaling pathway in MUC2 and CDX2 expression in BECs induced by PAMPs, BECs were pretreated with MG132 as an inhibitor of NF-kB, and then treated with LPS. Then, MUC2 and CDX2 expression in BECs was evaluated by RT-PCR and Western blotting.
Transfection Study
Transfection of CDX2 small interfering RNA Small interfering RNA (siRNA) for rat CDX2 and scramble siRNA as a negative control were purchased from Qiagen. The target sequence of rat CDX2 was 5 0 -CTGGTCTGTGTAA CAAGCCAA-3 0 , corresponding to the coding region 1870-1890. The siRNA was transfected into cultured BECs with DreamFectt. Briefly, 20 ml of 20 mM siRNA was diluted with 100 ml of OPTI-MEMI. DreamFectt was added to the siRNA, and gently mixed. The mixture was added to the culture medium with BECs. At 24 and 30 h after transfection, several groups of cultured BECs were treated with LPS, and cultured BECs were harvested, respectively.
Transfection of CDX2 expression vector
A CDX2 expression plasmid was constructed as described previously. 8 Empty vector was used as a negative control. Cultured BECs were transfected with this expression vector, using FuGENE 6 Transfection Reagent. Briefly, FuGENE 6 Reagent was diluted with OPTI-MEMI, and gently mixed. An amount of 2 mg of expression or empty vector was added to the diluted FuGENE 6 Reagent and incubated. The mixture was added to 2 ml of culture medium with BECs. At 24 h after transfection, BECs were harvested for RT-PCR and at 72 h after transfection, BECs were harvested for immunoblotting.
Identification of Bacterial Species in Bile
The identification of bacterial species in bile samples from PCK rats (10 months) was performed by PCR amplification with bacterial universal primers and sequencing as described previously. 26 Homology searches were performed with the alignment search tool BLAST on internet database (http:// www.blast.genome.ad.jp/).
Statistical Analysis
The Welch t-test or the Student's t-test and w 2 were used. Po0.05 was regarded as significant.
RESULTS

Animal Studies
Histology Multiple dilatation of intrahepatic bile ducts and fibrous expansion of portal tracts were observed in PCK rats. 25 At around 6 weeks, variable lymphocytic infiltration was focally seen around the dilated bile ducts (Figure 1a ). After 4-7 months, chronic cholangitis with suppurative changes and polymorphonuclear leukocytes (PMNs) in duct lumen (chronic suppurative cholangitis) became frequent, and at around 12-18 months, such changes were widespread in all PCK rats (Figure 1b ). The extent of chronic suppurative cholangitis with bile duct dilatation increased gradually with aging (Po0.05) ( Table 1) , and colonies of Gram-negative and/or -positive bacteria were identifiable in the duct lumen (Figure 1c ). Intestinal metaplasia with goblet cells was fre- Intestinal metaplasia of bile ducts H Ikeda et al quently found in the affected ducts (Figure 1d and e). None of these changes were present in control rats.
Expression of MUC2 and CDX2
MUC2 and CDX2 were immunohistochemically detected in BECs of the bile ducts showing chronic suppurative cholangitis and intestinal metaplasia. MUC2 was expressed in the cytoplasm of goblet cells, whereas CDX2 was expressed in the nuclei of goblet cells and adjacent columnar epithelial cells (Figure 2a-c) . There was no expression of MUC2 or CDX2 in other histologic components or cells in the liver except for BECs. By in situ hybridization (ISH), MUC2 and CDX2 mRNA were detected in the cytoplasm of goblet cells and in the cytoplasm of goblet cells and adjacent columnar epithelial cells, respectively (Figure 2d and f) . The distribution of mRNA-positive cells was the same as that of MUC2 and CDX2 protein-expressing cells. No signals were detected in these cells, when sense probes were used (Figure 2e and g) .
By Western blotting, CDX2 protein was detected in the whole liver tissue of PCK rats with marked chronic suppurative cholangitis and intestinal metaplasia at 10 and 16 months (Figure 3a) . In contrast, weak expression of CDX2 was seen in the liver tissue from PCK rats showing mild chronic cholangitis and no intestinal metaplasia. The liver samples from PCK rats showing no cholangitis and from control rats were negative for CDX2. Likewise, CDX2 protein was not detectable in the freshly isolated biliary tree from PCK rats showing cholangitis and intestinal metaplasia at 8 months (Figure 3b ).
Expression of TLR2 and TLR4
Immunohistochemically, TLR2 expression was barely seen in BECs of the ducts of control rats and PCK rats showing no inflammatory changes (Figure 4a ). In contrast, expression of TLR2 was evident in the cytoplasm and at the luminal surface of BECs in the affected ducts (Figure 4b ). TLR4 was expressed constitutively in the cytoplasm and at the luminal surface of BECs in the ducts of control and PCK rats ( Figure  4c and d).
Detection and identification of bacterial species By sequencing, 16S ribosomal RNA gene of Corynebacterium species (GenBank, Y09806), Pasteurella pneumotropica (GenBank AF012090), and Enterococcus faecalis (GenBank, Y18293) were detected in the bile samples from PCK rats.
Cultural Studies
Treatment with PAMPs and expression of CDX2 and MUC2 CDX2 and MUC2 at the mRNA and protein level were not detected in cultured BECs without treatment. Treatment with LPS, Pam3, LTA, and PGN upregulated CDX2 and MUC2 mRNA and protein expression in BECs (Figure 5a and b) . The CDX2 mRNA level in BECs treated with LPS increased in (Figure 6e and f) . In cultured BECs from control rats, LPS induced also CDX2 and MUC2 mRNA, and the expression was inhibited by anti-TLR4 antibody as seen in cultured BECs from PCK rats (Figure 6g ).
LPS-induced CDX2 and MUC2 expression and NF-kB inhibitor
Pretreatment of BECs with MG132 reduced the upregulated expression of CDX2 and MUC2 mRNA induced by LPS (Figure 7a ), and this reduction was also shown semiquantitatively (o0.05) (Figure 7b ). LPS-induced CDX2 and MUC2 protein expression was also inhibited with MG132 preincubation (Figure 7c ). 
DISCUSSION
This study showed that the intrahepatic bile ducts of PCK rats showed chronic suppurative cholangitis which became more frequent and widespread with aging. 25 Interestingly, this cholangitis was frequently associated with intestinal metaplasia with goblet cells, and MUC2 and CDX2 at protein and mRNA levels were detectable. MUC2 was mainly expressed in goblet cells, and CDX2 was detectable in nuclei of goblet cells and also surrounding columnar cells. The distribution of MUC2 and CDX2 expression is similar to that in previous reports in that MUC2 expression is restricted to the cytoplasm of goblet type cells and CDX2 is expressed extensively compared with MUC2. 1, 8, 17 CDX2 expression may be an early event in intestinal metaplasia because the expression of MUC2 is found within BECs that express CDX2. The extensive expression of CDX2 might suggest that CDX2 exists upstream in the pathogenesis of intestinal metaplasia.
In hepatolithiasis, the intrahepatic bile ducts show chronic cholangitis and intestinal metaplasia with goblet cells and aberrant MUC2 expression, and many kinds of bacteria species, especially Escherichia coli, were detected in bile of the affected ducts.
14-16 MUC2 is reportedly overexpressed in response to bacterial components, such as LPS or LTA, in cultured intestinal or airway epithelial cells and also BECs. 21, 27, 28 Therefore, it is possible that bacterial infection and/or bacterial components are responsible for the intestinal metaplasia and MUC2 expression in the affected ducts in hepatolithiasis. 20 In PCK rats, Gram-positive and -negative bacterial colonies were found in the lumen of ducts showing chronic suppurative cholangitis, and sequencing demonstrated Corynebacterium species, Enterococcus faecalis, and Pasteurella pneumotropica. The former two are normal microflora in the intestine and the latter is routinely isolated from the oral cavity in rats. It is possible that such bacterial infection or components were related to the development of intestinal metaplasia and MUC2 expression in these ducts. Cultural studies have showed that PAMPs such as LPS, Pam3, LTA, and PGN upregulated MUC2 expression in BECs of PCK rats. By using PCK rats and cultured BECs from PCK or control rats, we tried to clarify how bacterial components induce intestinal metaplasia and MUC2 expression in the ducts.
Recent studies showed that CDX2 regulates intestinal differentiation and MUC2 expression and is a key molecule for intestinal metaplasia. 2, [4] [5] [6] 8 Ectopic expression of CDX2 is known to induce intestinal phenotypes such as MUC2 expression in Barrett's esophagus, and bile acid or chronic acid exposure was speculated to induce CDX2 expression in esophageal keratinocytes. 8, 29 Inflammatory cytokines and infection may also induce CDX2 and then MUC2 expression.
2,4-6 For example, CDX2 expression was reportedly upregulated in cultured epithelial cells when they were infected with bacteria, and interactions of TLR with microbial components are involved in the regulation of MUC expression. [30] [31] [32] [33] [34] [35] Therefore, bacterial components in bile may induce CDX2 expression and then aberrant MUC2 expression in the ducts.
This study showed that treatment with PAMPs such as LPS, Pam3, LTA, and PGN upregulated CDX2 expression in cultured BECs, and the level of CDX2 mRNA was increased by LPS in a dose-dependent manner. LPS treatment induced CDX2 and MUC2 expression in the nuclei and cytoplasm of BECs were stimulated with 0.1, 1, and 10 mg/ml LPS for 6 h before assessment of CDX2 and MUC2 mRNA expression in the cell lysate. A CDX2 band is evident with 1 mg/ml LPS and more so with 10 mg/ml LPS, whereas a band of MUC2 mRNA is present only on stimulation with 10 mg/ml, not 0.1 or 1 mg/ml LPS. The relative increase in signals of CDX2 at 0.1, 1, and 10 mg/ml LPS) is shown in the graph. Dose-dependent increased expression of CDX2 mRNA is significantly evident. A band of MUC2 mRNA is present only on stimulation with 10 mg/ml but not 0.1 or 1 mg/ml LPS. *Po0.05, when compared with 0.1 mg/ml treatment, **Po0.05, when compared with 1 mg/ml treatment. 
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TLRs are receptors recognizing PAMPs, and are reportedly expressed in the BECs of the biliary tree. 35 Among them, TLR2 and TLR4 are major receptors for bacterial components. [22] [23] [24] This study also showed that in PCK rats, TLR2 was expressed in BECs of the bile ducts with chronic suppurative cholangitis, whereas TLR4 was expressed constitutively in BECs. In addition, TLR2 and TLR4 at the mRNA and protein level were detected in cultured BECs without treatment. Interestingly, preincubation with anti-TLR4 antibody or anti-TLR2 antibody downregulated CDX2 and MUC2 expression in BECs induced by LPS (a ligand for TLR4) or Pam3 (a ligand for TLR2), respectively, Interaction of TLR with PAMPs is known to activate intracellular signals followed by NF-kB translocation and the synthesis of molecules including inflammatory cytokines. 24, 35 The involvement of TLR2 and/or TLR4 in Helicobacter pylori infections has been revealed in cultured gastric epithelial cell lines, 33, 34 in which MUC2 was induced to express by TLR2/ bacterial components and the activation of NF-kB. 3, 31, 32 PAMPs-induced CDX2 and MUC2 overexpression via an NF-kB pathway located downstream of TLRs. This study showed that pretreatment of BECs with MG132 reduced the CDX2 and MUC2 mRNA upregulation induced by LPS, suggesting that upregulation of the CDX2 and MUC2 pathway by PAMPs was related to the activation of TLR2/ TLR4 with the translocation of NF-kB.
Recent studies showed that CDX2 regulates MUC2 expression. 6, 8 Yamamoto et al 6 reported that transfected CDX2 expression constructs activated the MUC2 promoter and increased the MUC2 mRNA level. 6, 8 We showed that LPSinduced CDX2 and MUC2 mRNA expression in cultured BECs disappeared on transfection of CDX2 siRNA, and that forced expression of CDX2 by using the CDX2 expression vector upregulated MUC2 expression in cultured BECs, supporting reports that CDX2 exists upstream of MUC2 and activates transcription of MUC2. 6, 8 However, it is also known that MUC2 has NF-kB-binding sites in the promoter region, 32, 36 and the activation of NF-kB could directly trigger (Figure 7a ). This raises the possibility that inhibition of NF-kB leads indirectly to decreased expression of MUC2 mRNA via a decrease in CDX2 mRNA and also directly to decreased expression of MUC2 mRNA. Taken together, it seems plausible that although the activation of CDX2 may be the predominant pathway in the upregulation of MUC2 expression in rat BECs, there may be other pathway(s) leading to increased transcription of MUC2 in cultured BECs. More studies are mandatory to clarify this issue in BECs. Cultured BECs transfected with the CDX2 expression vector showed immunohistochemically CDX2 expression in the nucleus and MUC2 in the cytoplasm. In PCK rats, CDX2 and MUC2 were also expressed in the nucleus and cytoplasm of goblet cells, respectively. Taken together, the expression of MUC2 in cultured BECs and probably in goblet cells in metaplastic bile ducts may be mediated via upregulated CDX2. Columnar epithelium expressing nuclear CDX2 but not MUC2 around goblet cells in the bile ducts ( Figure  2a-c) may be an early change of goblet cells, as CDX2 is also involved in the differentiation of goblet cells. 6 Intestinal metaplasia is significantly involved in the pathogenesis of biliary diseases. For example, chronic cholangitis in hepatolithiasis, an intractable disease, shows intestinal and gastric metaplasia of lining BECs expressing MUC2. [10] [11] [12] 16 MUC2 is also expressed in the intraductal papillary neoplasm of bile ducts (IPNB) showing intraductal growth and secreting much mucin. 1, [37] [38] [39] [40] [41] IPNB is known to be associated with hepatolithiasis. 39, 40 So, therapeutic approaches targeting MUC2 and CDX2 would be promising in patients with these biliary diseases.
In conclusion, this study using PCK rats showed that the interaction of PAMPs with TLR2/4 followed by the activation of NF-kB led to the upregulation of CDX2 expression and 
